Cell & Gene Meeting on the Mediterranean

Date

Promethera's President & CEO John Tchelingerian has been invited to participate on the panel on "International deal-making environment" on 24th April.  Founder and CSMO prof dr Etienne Sokal has been scheduled for a company presentation to highlight the companies activities and to give an update on the development of HepaStem for the treatment of fibro-inflammatory liver diseases.  The conference is organized by ARM (Alliance for Regenerative Medicine) and will be held in Barcelona.

Sign Up